EndoStim

EndoStim is a small medical device company headquartered in Dallas, Texas, with a team of four employees. The company generates approximately $5 million in annual revenue. EndoStim develops and commercializes a groundbreaking neurostimulation treatment system for individuals suffering from drug-resistant gastroesophageal reflux disease (GERD). Their therapy aims to restore normal esophageal function without resorting to traditional anti-reflux surgery, which often carries significant gastrointestinal side effects. The EndoStim System is designed to provide long-lasting reflux control. The EndoStim System consists of an implantable neurostimulation device and a lead, implanted through a minimally invasive laparoscopic procedure. This system continuously delivers mild electrical signals to the patient's lower esophageal sphincter (LES) muscle, the root cause of GERD, helping it function correctly. The system is programmed wirelessly by a physician using an external handheld controller, ensuring patient comfort as the stimulation is undetectable. For further information about EndoStim and their innovative GERD treatment, please visit their website at endostim.com.